U.S. Markets closed

Lexicon Pharmaceuticals Inc (LXRX) President and CEO Lonnel Coats Bought $376,200 of Shares

- By insider

President and CEO of Lexicon Pharmaceuticals Inc (LXRX) Lonnel Coats bought 30,000 shares of LXRX on 09/15/2017 at an average price of $12.54 a share. The total cost of this purchase was $376,200.

Lexicon Pharmaceuticals Inc operates as a biopharmaceutical company engaged in discovery and development of breakthrough treatments for human disease. The company mainly designs and develops drugs for therapeutic areas. Lexicon Pharmaceuticals Inc has a market cap of $1.31 billion; its shares were traded at around $12.37 with and P/S ratio of 15.92.


CEO Recent Trades:

  • President and CEO Lonnel Coats bought 30,000 shares of LXRX stock on 09/15/2017 at the average price of $12.54. The price of the stock has decreased by 1.36% since.

Directors and Officers Recent Trades:

  • Director Sam L Barker bought 1,000 shares of LXRX stock on 09/15/2017 at the average price of $12.5. The price of the stock has decreased by 1.04% since.

For the complete insider trading history of LXRX, click here

.This article first appeared on GuruFocus.